Devyser Diagnostics AB publishes Year-End Report for the period January to December 2022
“Further strong organic growth was reported for the year and quarter. Efforts to build an international marketing and sales organization are starting to pay off. I am confident that we will achieve our important financial target of generating an operating margin of more than 20% starting sometime in 2024/2026.” Fredrik Alpsten, CEO, Devyser Quarter October-December 2022 · Net sales amounted to SEK 34.2 million (24.5), corresponding to a 39.5% increase. Adjusted for exchange rate fluctuations, net sales increased by 29.8%. · Gross profit totaled SEK 27.2 million (18.5),